COLUMBIA, Missouri, April 27 -- The Association of Health Care Journalists issued the following commentary on April 26, 2024: * * * How to Cover the Sharp Rise in Spending for Diabetes and Weight Loss Drugs By Joseph Burns and Liz Seegert In three years, prescriptions for a new class of weight loss drugs (called GLP-1 receptor agonists) have been so robust that they rank among the top-selling medications in Medicare's prescription-drug program, according to a new report from KFF. The report  more